Zoetis Cash Flow Statement
NYSE: ZTSHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Zoetis free cash flow
In fiscal 2025, Zoetis generated $2.90 billion of operating cash flow and spent $621.0 million on capital expenditures. That left free cash flow of $2.28 billion, a free-cash-flow margin of 24.1% of revenue. Free cash flow was down 0.7% from the prior year's $2.30 billion.
Zoetis returned $4.12 billion to shareholders: $889.0 million in dividends and $3.23 billion in share repurchases, equal to 181% of free cash flow. Free cash flow covered dividend payments 2.6 times.
Summary generated from market data by MetaCap's automated system. Methodology
Zoetis cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.67B | 2.50B | 2.34B | 2.11B | 2.03B | 1.64B | 1.50B | 1.42B | 862.00M | 819.00M |
| Net Income growth (YoY) | +7.09% | +6.67% | +10.85% | +3.79% | +24.33% | +9.07% | +5.34% | +65.20% | +5.25% | +141.59% |
| Depreciation & Amortization | 487.00M | 497.00M | 491.00M | 465.00M | 448.00M | 441.00M | 412.00M | 308.00M | 242.00M | 240.00M |
| Stock-Based Compensation | 83.00M | 74.00M | 60.00M | 62.00M | 58.00M | 59.00M | 67.00M | 53.00M | 44.00M | 37.00M |
| Change in Working Capital | -469.00M | 96.00M | -478.00M | -797.00M | -318.00M | -102.00M | -143.00M | 45.00M | -95.00M | -454.00M |
| Operating Cash Flow | 2.90B | 2.95B | 2.35B | 1.91B | 2.21B | 2.13B | 1.79B | 1.79B | 1.35B | 713.00M |
| Capital Expenditures | -621.00M | -655.00M | -732.00M | -586.00M | -477.00M | -453.00M | -460.00M | -338.00M | -224.00M | -216.00M |
| Investing Cash Flow | -748.00M | -315.00M | -777.00M | -883.00M | -458.00M | -572.00M | -504.00M | -2.26B | -270.00M | -214.00M |
| Dividends Paid | -889.00M | -786.00M | -692.00M | -611.00M | -474.00M | -380.00M | -314.00M | -243.00M | -206.00M | -188.00M |
| Share Repurchases | -3.23B | -1.86B | -1.09B | -1.59B | -743.00M | -250.00M | -626.00M | -698.00M | -500.00M | -300.00M |
| Debt Issued | 1.85B | 0 | 0 | 1.35B | 0 | 1.24B | 0 | 1.50B | 1.23B | 0 |
| Debt Repaid | -1.35B | 0 | -1.35B | 0 | -600.00M | -500.00M | 0 | 0 | -750.00M | -400.00M |
| Financing Cash Flow | -1.87B | -2.66B | -3.11B | -904.00M | -1.86B | 123.00M | -951.00M | 533.00M | -251.00M | -903.00M |
| Net Change in Cash | 325.00M | -54.00M | -1.54B | 96.00M | -119.00M | 1.67B | 332.00M | 38.00M | 837.00M | -427.00M |
| Free Cash Flow | 2.28B | 2.30B | 1.62B | 1.33B | 1.74B | 1.67B | 1.33B | 1.45B | 1.12B | 497.00M |
This table shows 10 annual periods of Zoetis's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ZTS's reporting calendar. What is a cash flow statement?